NCT00789971View on ClinicalTrials.gov

Triamcinolone Versus Topical Treatment in Post Operative Phacoemulsification

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

April 30, 2008

Conditions
Ocular Inflammation
Interventions
DRUG

triamcinolone acetonide

40 mg of triamcinolone acetonide given inferotemporally perioperatively during phacoemulsification

DRUG

Maxitriol

one month of topical G. Dexamethasone 0.1% with Neomycin sulphate 3500IU/g

Trial Locations (1)

Unknown

Sligo General Hospital, Sligo

All Listed Sponsors
lead

Sligo General Hospital

OTHER

NCT00789971 - Triamcinolone Versus Topical Treatment in Post Operative Phacoemulsification | Biotech Hunter | Biotech Hunter